8-K filing — QuidelOrtho Corp (QDEL)
Filed: 2026-09-23 AccNo: 0001906324-26-000036 Size: 799 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
QuidelOrtho shares are trading lower after the company reported Q2 financial results and cut its FY26 guidance below estimates.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035
The global lateral flow assay market is projected to grow from USD 10.84 billion in 2025 to USD 17.66 billion by 2035, with a 5.0% CAGR. Growth is driven by increased adoption of point-of-care testing, technological innovations including CRISPR-based assays, and the shift toward decentralized diagnostic models. Major players include Abbott, Roche, Siemens Healthineers, and Thermo Fisher Scientific, with infectious disease testing accounting for 72.2% of market share.
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July
US stocks higher, Nasdaq up 300 pts. Dow +0.3%, Nasdaq +1.2%, S&P 500 +0.58%. Materials and Doximity Inc surge. Nonfarm payrolls contract, unemployment rate at 4.1%. Oil +0.5%, gold +2.4%, silver +3.5%. European shares higher, Asian markets mixed.
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.